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Previous evidence suggests that the inheritance of bipolar disorder (BP) may vary depending on the age at onset
(AAO). Therefore, we sought to incorporate AAO as a covariate in linkage analyses of BP using two different
methods, LODPAL and ordered-subset analysis (OSA), in genomewide scans of 150 multiplex pedigrees with 874
individuals. The LODPAL analysis identiﬁed two loci, on chromosomes 21q22.13 (LOD p 3.29; empirical chro-
mosomewide P value p .009) and 18p11.2 (LOD p 2.83; empirical chromosomewide P p .05), with increased
linkage among subjects who had early onset (AAO  21 years) and later onset (AAO 121 years), respectively. The
ﬁnding on 21q22.13 was signiﬁcant at the chromosomewide level, even after correction for multiple testing. More-
over, a similar ﬁnding was observed in an independent sample of 65 pedigrees (LOD p 2.88; empirical chromo-
somewide P p .025). The ﬁnding on 18p11.2 was only nominally signiﬁcant and was not observed in the inde-
pendent sample. However, 18p11.2 emerged as one of the strongest regions in the OSA (LOD p 2.92; empirical
P p .001), in which it was the only ﬁnding to meet chromosomewide levels of signiﬁcance after correction for
multiple testing. These results suggest that 21q22.13 and 18p11.2 may harbor genes that increase the risks for
early-onset and later-onset forms of BP, respectively. There have been previous reports of linkage on 21q22.13 and
18p11.2, but the ﬁndings have not been consistent. This inconsistency may be due to differences in the AAO
characteristics of the samples examined. Future studies to ﬁne map susceptibility genes for BP on chromosomes
21q22.13 and 18p11.2 should take AAO into account.
Introduction
Bipolar disorder (BP) is a severe psychiatric disorder that
manifests with alternating episodes of mania and depres-
sion. Although family, twin, and adoption studies sug-
gest that BP has a strong genetic component, efforts to
identify susceptibility genes have thus far yielded incon-
sistent results. The difﬁculties may be attributable to
genetic (locus) heterogeneity. If a sample consists of sub-
jects harboring different susceptibility genes, then the
linkage signal at any one locus may be attenuated.More-
over, even if a linkage signal is identiﬁed, it may be
difﬁcult to replicate the ﬁnding in another sample that
contains a different mixture of affected subjects. By using
a clinical feature that is related to the underlying genetic
heterogeneity, we may be able to identify more etiolog-
ically homogeneous subgroups and thereby increase the
chances of successfully mapping susceptibility genes for
BP.
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Age at onset (AAO) is a potential clinical marker of
genetic heterogeneity in BP. Previous studies suggest that
there may be several subgroups of BP with distinct but
overlapping distributions of AAO (Bellivier et al. 2001,
2003; Lin et al., in press). It has been shown that the
rates of psychiatric comorbidities and clinical indicators
of severity (e.g., a suicide attempt) vary across different
AAO subgroups (Carlson et al. 1977, 2000; Carter et
al. 2003; Lin et al., in press), and AAO subgroups ag-
gregate in families, such that affected relatives typically
have similar AAOs (McElroy et al. 2001; O’Mahony et
al. 2002; Lin et al., in press). Additionally, a segregation
analysis (Grigoroiu-Serbanescu et al. 2001) found that
the pattern of transmission of BP in families differs with
AAO. These lines of evidence support the argument that
AAO is a heritable characteristic of BP and may be used
to facilitate the search for susceptibility genes.
There are several approaches to incorporating infor-
mation about AAO, as well as other covariates, into
linkage analyses of complex disorders (e.g., see Green-
wood and Bull 1997; Devlin et al. 2002; Glidden et al.
2003). One approach is to test for linkage directly to
AAO as a quantitative trait. Other approaches treat AAO
as a covariate rather than the phenotype of interest. These
approaches may be classiﬁed into two categories. The
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Figure 1 LOD scores along chromosome 21, from the LODPAL
analyses of the NIMH sample ( families) and replication sam-np 150
ple ( families). Results from the one-covariate model with AAOnp 65
as a dichotomous variable under the broad- and narrow-phenotype
models are shown. For the sake of clarity, baseline models without
AAO, which generally yielded LOD scores !0.05, are not shown. The
peak ﬁnding on chromosome 22q22.13 in the NIMH sample was ∼2.5
Mb away from the peak ﬁnding in the replication sample. In both
samples, the increased evidence of linkage was observed among af-
fected subjects with early-onset BP ( years).AAO  21
ﬁrst considers the family as the unit of analysis. In this
case, families are stratiﬁed (or are grouped using some-
thing conceptually akin to stratiﬁcation) according to
AAO, and linkage is examined in the resulting sub-
groups. Hauser and colleagues (2004) recently intro-
duced a method called “ordered-subset analysis” (OSA)
that allows a systematic search for linkage in deﬁned
subgroups of families. The second category considers
the relative pairs as the unit of analysis. An example of
such an approach has been introduced by Olson (1999)
and is implemented in the program LODPAL (Goddard
et al. 2001). It builds on the affected sib pair (ASP)
LOD score analysis proposed by Risch (1990) and al-
lows for inclusion of covariates deﬁned at the level of
the relative pair.
The National Institute of Mental Health (NIMH) Ge-
netics Initiative for Bipolar Disorder was established as
a multisite collaborative effort to collect one of the larg-
est samples of families for genetic investigations of BP
by use of common methods of ascertainment and as-
sessment. These families were genotyped in two waves
consisting of 97 and 56 families. Analyses of the ﬁrst
wave of families (Detera-Wadleigh et al. 1997; Edenberg
et al. 1997; Rice et al. 1997; Stine et al. 1997) yielded
some evidence of linkage on chromosomes 5q, 6q, 7p,
7q, 9q, 10q, 13q, 15p, 16p, 21q, Xp, and Xq. However,
the ﬁndings were not sustained in analyses of the second
wave of families (Dick et al. 2002; Willour et al. 2003;
Zandi et al. 2003), except for the ﬁnding on 16p. Mc-
Innis et al. (2003a) subsequently combined the data from
the two waves of families and performed a genomewide
scan of the entire data set. They observed three peak
linkage signals with a LOD score 12.0, on 16p13,
20p12, and 10p12, but none of the ﬁndings reached
conventional levels of signiﬁcance. The inconsistent
ﬁndings across samples and the lack of results reaching
conventional levels of signiﬁcance are characteristic of
linkage studies of BP and point to the heterogeneity of
the condition.
By incorporating information about AAO, we may
be able to reveal the underlying heterogeneity in BP and
thereby facilitate the mapping of bipolar susceptibility
genes. Faraone and colleagues (2004) recently examined
the ﬁrst wave of the NIMH Genetics Initiative families
by using AAO as a quantitative trait, and they reported
linkage on chromosomes 12, 14, and 15. Here, we re-
port the results of a linkage analysis of the combined
data from the ﬁrst and second waves of families (Mc-
Innis et al. 2003a), using both relative-pair and family-
level covariate methods.
Subjects and Methods
Ascertainment and Assessment
The ascertainment and assessment of the subjects have
been described in detail elsewhere (McInnis et al. 2003a).
In brief, the sample was collected as part of the NIMH
Genetics Initiative for Bipolar Disorder. Pedigrees were
ascertained through probands with bipolar I disorder
(BPI) by inclusion criteria consistent across four sites:
Indiana University, Washington University in St. Louis,
The Johns Hopkins University, and the NIMH. Inclusion
criteria for families were as follows: (1) there was at
least one other ﬁrst-degree relative affected with either
BPI or schizoaffective disorder, bipolar type (SABP); (2)
either the proband or a second affected relative had at
least two living siblings aged 18 years; and (3) only
one parent was affected with BPI or SABP (i.e., it was
a unilineal family). The diagnoses of BPI and SABP were
based on Diagnostic and Statistical Manual of Mental
Disorders, 3rd edition (DSM-IIIR) criteria (American
Psychiatric Association 1987). The diagnoses of bipolar
II disorder (BPII) and recurrent major depression (RMD)
were based on modiﬁed Research Diagnostic Criteria
(Gershon et al. 1989). Investigators used the semistruc-
tured Diagnostic Interview for Genetic Studies (DIGS)
(Nurnberger et al. 1994) and the Family Interview for
Genetic Studies to assess key diagnoses, comorbid psy-
chiatric diagnoses, and clinical features. All diagnoses
were made by best-estimate procedures based on the con-
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sensus of two noninterviewing psychiatrists. We chose
two phenotype models for linkage analysis: a narrow-
phenotype model that included SABP, BPI, and BPII and
a broad-phenotype model that included SABP, BPI, BPII,
and RMD. AAO was deﬁned as the self-reported age at
the ﬁrst episode of depression or mania that met diag-
nostic criteria.
Genotyping
A total of 153 pedigrees were genotyped in two
waves. There were 97 pedigrees in the ﬁrst wave and 56
pedigrees in the second wave. Genotyping was done at
one of the four above-mentioned institutions by use of
PCR-based methods performed using either ﬂuorescent
dye–labeled primers resolved on a DNA sequencer or
radiolabeled primers with PAGE and autoradiography
(Detera-Wadleigh et al. 1997; Edenberg et al. 1997; Rice
et al. 1997; Stine et al. 1997; Dick et al. 2002; Willour
et al. 2003; Zandi et al. 2003). A total of 425 markers
were genotyped in the ﬁrst 97 pedigrees, and 378 mark-
ers were genotyped in the remaining 56 pedigrees (fur-
ther information about the genotyped markers is avail-
able at the Center for Collaborative Genetic Studies on
Mental Disorders Web site). Of these, 298 markers were
genotyped in common across both sets. To align the
allele bins of the common markers, we used data from
two CEPH control subjects who were genotyped across
pedigree sets and/or allele frequencies. For quality con-
trol, we used the programs Genetic Analysis System
(Young 1995) and UNKNOWN (Lathrop et al. 1984)
to check for inheritance inconsistencies. We then used
the chrompic routine of CRIMAP (Lander et al. 1987)
to check for unlikely double recombinations. Finally, we
used the pedigree relationship statistical test (Sun et al.
2002) to check for family-relationship inconsistencies by
use of genomewide data. Identiﬁed inconsistencies were
resolved by deleting the problematic genotypes. The in-
consistencies could not be resolved in three pedigrees;
these pedigrees were therefore removed from the sample.
This left 150 pedigrees containing 874 individuals for
the linkage analyses.
Replication Sample
We used an independent sample consisting of 65 pedi-
grees, to further explore our positive linkage ﬁndings.
This sample has been described in detail elsewhere
(McInnis et al. 2003b). The pedigrees were ascertained
through probands with BPI who had to have at least
two affected ﬁrst-degree relatives. All subjects were as-
sessed by trained psychiatrists using the Schedule for Af-
fective Disorders and Schizophrenia–Lifetime Version
(Endicott and Spitzer 1978), and diagnoses were as-
signed using best-estimate procedures with Research Di-
agnostic Criteria (Endicott and Spitzer 1979). The geno-
typing for these 65 families was performed at The Johns
Hopkins University, Stanford University, and the Center
for Inherited Disease Research (for further details of the
markers studied, see the work byMcInnis et al. [2003b]).
Quality control for the genotyping was performed using
the same procedures described above.
Statistical Analyses
We used the following procedures to construct genetic
maps of the markers genotyped in both the initial and
replication samples. First, we ordered the markers using
the physical sequence databases. We then obtained ge-
netic map distances between markers by analyzing our
data with CRIMAP. Finally, we compared our maps for
consistency with the publishedmaps fromMarshﬁeld and
deCODE.
We then analyzed the genotype data using two differ-
ent covariate-based linkage methods. First, we used an
affected relative pair approach implemented in the pro-
gram LODPAL of the S.A.G.E. package (version 4.4).
The approach was ﬁrst introduced by Olson (1999) and
was later modiﬁed by Goddard et al. (2001). It is based
on a conditional logistic parameterization of the recur-
rence risk ratios for offspring andMZ twins, conditional
on any number of covariates. The model estimates a
parameter for the “average” linkage in the sample, as
well as parameters for the change in linkage as a function
of the included covariates. These parameters can be used
to estimate the relative recurrence risk ratios as a func-
tion of the covariates.
We examined the effect of AAO on linkage by com-
paring models with and without AAO entered as a co-
variate. We treated AAO as either a continuous or a di-
chotomous variable. We dichotomized AAO at age 21
years (21 vs. 121) on the basis of previous evidence
that this cutoff empirically distinguished early- and later-
onset forms of the disease (Lin et al., in press). The AAO
covariates were entered into the linkage model as the
sum of the values for the two individuals in each affected
relative pair. The summed covariates were then centered
on their sample mean before parameter estimation.
Results are reported as LOD scores, where the LOD
score equals the likelihood-ratio statistic (LRS) from the
ﬁtted model divided by 4.605 (i.e., ). Signiﬁ-2# log 10e
cance values were derived on the basis of the asymptotic
distribution of the LRS. The distribution of the LRS for
the baseline model with no covariates is a 50:50 mixture
of a point mass at 0 and a x2 distribution with 1 df. The
distribution of the LRS for the one-covariate model is a
50:50 mixture of x2 distributions with 1 df and 2 df. To
test the signiﬁcance of the covariate effect, the LRS dif-
ference between models with and without the covariate
can be compared with a x2 distribution with 1 df.
Because asymptotic P values estimated on the basis of
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Table 1
Characteristics of the Families in the NIMH Genetics Initiative and Replication Samples
CHARACTERISTIC
NIMH SAMPLE REPLICATION SAMPLE
Narrow Phenotype Broad Phenotype Narrow Phenotype Broad Phenotype
No. of affected subjects 510 638 231 298
No. (%) of affected femalesa 299 (58.6) 387 (60.7) 134 (58.0) 183 (61.4)
Mean no. of affected subjects per family 3.7 4.2 3.5 4.6
Range of no. of affected subjects per family 1–8 2–10 1–9 2–10
No. of all possible affected relative pairs 730 1,038 260 506
Mean  SD AAOa (years) 20.8  9.5 22.0  10.7 22.1  9.9 23.1  10.5
Range of AAO (years) 5–60 5–76 6–80 4–80
No. (%) of subjects with early onset
( years)aAAO  21
327 (64.6) 385 (61.0) 137 (59.6) 163 (54.9)
No. (%) of subjects with late onset
( years)aAAO 1 21
179 (35.4) 246 (39.0) 93 (40.4) 134 (45.1)
Range of mean AAO per family (years) 7.7–35 9.8–39.3 13–38 14–34
Range of minimum AAO per family (years) 5–31 5–31 6–38 4–26
NOTE.—The NIMH sample comprised 150 families, including 874 genotyped individuals. The replication sample comprised 65
families, including 561 genotyped individuals.
a T tests were used to compare continuous variables, and x2 tests were used to compare categorical variables across samples;
none were found to be signiﬁcantly different ( ).P ! .05
a mixture of x2 distributions may be liberal, we further
evaluated the signiﬁcance of our best ﬁndings using per-
mutation methods. To test the covariate effect of AAO
on linkage at a locus, we randomly permuted the AAO
covariate values among the affected relative pairs 1,000
times. We then analyzed each replicate with LODPAL
to determine the number of times that, across the chro-
mosome, there was an increase in the LOD score from
that in the observed data set. This number, divided by
1,000, was taken as the empirical chromosomewide P
value for the covariate effect. Similarly, to test the overall
linkage at a locus with AAO entered as a covariate, we
kept the AAO covariate ﬁxed but randomly permuted
the genotypes based on our families and the pattern of
missing data 1,000 times, using the simulation package
in Merlin. We then analyzed each replicate with LOD-
PAL to determine the number of times that, across the
chromosome, there was a LOD score as high as that in
the original data. This number, divided by 1,000, was
taken as the empirical chromosomewide P value for
overall linkage. Because we evaluated two phenotype
models and incorporated AAO as both a continuous and
a dichotomous covariate, we corrected the chromosome-
wide signiﬁcance level by dividing 0.05 by 4 ( ).p 0.0125
To account for all 22 autosomal chromosomes tested,
we corrected the genomewide signiﬁcance level by di-
viding 0.0125 by 22 ( ).p 0.0006
The second covariate-based linkage method we used
was OSA, as implemented in OSA software, version 2.1
(Hauser et al. 2004). OSA tests for linkage in subsets of
families deﬁned by different covariate values, without
having to choose arbitrary cutoff points for the covari-
ate. The ﬁrst step in performing an OSA is to assign a
covariate value to each family. We used two deﬁnitions
for AAO: the mean and minimum values of AAO for
all affected subjects in a family. OSA then uses the ASM
module implemented in GENEHUNTER-PLUS (Kong
and Cox 1997) to calculate allele-sharing LOD scores
with the Spair statistic and a linear model in successive
subsets of the families by the following procedures. First,
families are ranked according to their covariate values
in both low-to-high and high-to-low directions. Families
with the same covariate values are assigned the same rank.
Second, allele-sharing LOD scores are estimated across
a chromosome in the ﬁrst-ranked family. Third, the sec-
ond-ranked family is added to the subset of families, and
the allele-sharing LOD scores are recalculated. Fourth,
the procedures are repeated, as higher-ranked families
are added one by one, until all families are analyzed as
a ﬁnal subset. The maximum allele-sharing LOD scores
for each subset of families and the positions where the
maximum scores occurred are recorded.
To assess the signiﬁcance of any increment between
LOD scores obtained in a subset, we used the permuta-
tion tests available in the OSA software package to cal-
culate empirical P values. These permutation tests were
performed by randomly ordering the families with the
same number of ranks as in the original analysis. A total
of 10,000 randomized ordered samples were generated,
and maximum LOD scores were obtained through the
OSA procedures described above. We counted events for
which the maximum allele-sharing LOD score detected
at any position along the chromosome was greater than
or equal to the original subset maximum LOD score.
The number of such events per 10,000 was considered
to be the empirical chromosomewide P value. Because we
examined two phenotype models, two covariates (i.e.,
mean and minimum AAO values), and two directional
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Figure 2 Genomewide scan results from the LODPAL analysis
under the narrow-phenotype model.
Figure 3 Genomewide scan results from the LODPAL analysis
under the broad-phenotype model.
orders (low-to-high and high-to-low), we corrected the
chromosomewide signiﬁcance level by dividing 0.05 by
8 ( ). To adjust for 22 autosomal chromosomesp 0.00625
in the genome scan, the genomewide signiﬁcance level
was calculated as 0.00625 divided by 22 ( ).p 0.0003
Results
The NIMH Genetics Initiative sample consisted of 874
genotyped subjects in 150 pedigrees. A total of 638 sub-
jects were diagnosed with a major mood disorder, in-
cluding 363 (56.9%) with BPI, 37 (5.8%) with SABP,
110 (17.2%) with BPII, and 128 (20.1%) with RMD.
The replication sample consisted of 561 genotyped sub-
jects in 65 pedigrees. A total of 298 subjects were diag-
nosed with a major mood disorder, including 7 (2.4%)
with SABP, 127 (42.6%)with BPI, 97 (32.5%)with BPII,
and 67 (22.5%) with RMD. The subjects and the AAO
characteristics for the two samples are further described
in table 1. These two samples did not differ signiﬁcantly
in terms of sex composition or AAO characteristics.
The LODPAL analyses revealed two chromosomal
regions of interest where the LOD score increased by
12 after AAO was included as a covariate in analyses
under either the narrow-phenotype or the broad-pheno-
type model. The most signiﬁcant region was on chro-
mosome 21 (see ﬁg. 1). Under the broad-phenotype
model, the LOD score increased from 0.02 to 3.29 (for
the increase in LOD, ; for the overall LOD,Pp .0001
) on chromosome 21q22.13 near markerPp .0003
D21S1252 (chromosome 21: 36,647,255–36,847,595
bp) with AAO treated as a dichotomous variable. Permu-
tation tests at this locus yielded an empirical chromo-
somewide P value of .006 for the increase in LOD and
.009 for the overall LOD. The 1-LOD support interval
was ∼6 cM, from markerD21S1254 toD21S1252. The
estimated parameter for AAO at this locus was negative,
which suggests that the evidence for linkage was greatest
among subjects with early-onset BP. We estimated that
the sibling recurrence risk at this locus decreased from
1.60 for subjects with an AAO of 6 years to 0.75 for
subjects with an AAO of 34 years.
Under the narrow-phenotype model, the LOD score
increased from 0.12 to 2.24 (for the increase in LOD,
; for the overall LOD, ) on chro-Pp .0018 Pp .0035
mosome 21q22.11 near marker D21S65 (chromosome
21: 34,909,475–35,109,672 bp) whenAAOwas treated
as a dichotomous variable. However, the LOD score at
this locus increased even more, to 3.20 (for the increase
in LOD, ; for the overall LOD, )Pp .0001 Pp .0004
when AAO was treated as a continuous variable (see
ﬁgs. 2–5). Additionally, a neighboring peak emerged at
marker pfkl (chromosome 21: 44,576,175–44,603,450
bp) in the gene for phosphofructokinase, liver type (PFKL
[MIM 171860]). Here, the LOD score increased from
0.00 to 2.98 (for the increase in LOD, ; forPp .0002
the overall LOD, ). It is difﬁcult to determinePp .0006
whether the two neighboring peaks represented the same
or distinct loci. Consistent with the ﬁndings for the
broad-phenotype model, the evidence of linkage at these
loci was greatest among subjects with early-onset disease.
The other ﬁnding of interest was on chromosome 18
(see ﬁg. 6). Under the broad-phenotype model, the LOD
score increased from 0.35 to 2.83 (for the increase in
LOD, ; for the overall LOD, ) onPp .0007 Pp .0009
chromosome 18p11.2 nearmarkerD18S1150 (chromo-
some 18: 10,136,591–10,336,929 bp), when AAO was
treated as a continuous variable. Permutation tests in
this region yielded an empirical chromosomewide P
value of .018 for the increase in LOD and .05 for the
overall LOD. The 1-LOD support interval was ∼10 cM,
from marker D18S1150 to D18S40. The regression co-
efﬁcient for the AAO covariate was positive, suggesting
that the evidence of linkage was greatest among those
with later AAO. We estimate that the sibling recurrence
risk at this locus ranged from 0.64 for subjects with an
AAO of 6 years to 1.58 for subjects with an AAO of
34 years. The ﬁndings were not as compelling under the
narrow-phenotype model. Here, the LOD score in-
creased from 0.42 to 1.47 (for the increase in LOD,
; for the overall LOD, ) on chromo-Pp .028 Pp .022
some 18p11.2 near marker D18S40 (chromosome 18:
13,643,793–13,843,883 bp).
We sought to further explore the ﬁndings with AAO
on chromosomes 21q22.13 and 18p11.2 in an indepen-
dent sample of 65 pedigrees. The results were similar
on chromosome 21q22.13 (see ﬁg. 1) but not 18p11.2.
At marker D21S1444 (chromosome 21: 38,179,973–
38,380,289 bp) the LOD score increased from 0.28 to
2.32 (for the increase in LOD, ; for the over-Pp .0056
all LOD, ) when examined under the broad-Pp .0022
phenotype model and with AAO treated as a dichoto-
mous variable. At a neighboring marker,D21S156 (chro-
mosome 21: 39,156,176–39,356,252 bp), the LOD
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Figure 4 Genomewide scan results from the OSA under the
narrow-phenotype model. The legend is available in its entirety in the
online edition of The American Journal of Human Genetics.
Figure 5 Genomewide scan results from the OSA under the
broad-phenotype model. The legend is available in its entirety in the
online edition of The American Journal of Human Genetics.
score similarly increased from 0.65 to 2.88 (for the in-
crease in LOD, ; for the overall LOD,Pp .0036 Pp
). Permutation tests at this marker yielded an em-.0014
pirical chromosomewide P value of .012 for the increase
in LOD and .025 for the overall LOD. Markers
D21S144 and D21S156 are ∼1.5 and 2.5 Mb away,
respectively, from the peak signal observed in the initial
sample. The regression coefﬁcient for the AAO covar-
iate was negative for these two markers, again sug-
gesting that linkage at this locus was greatest among
those with younger AAO.
OSA of the NIMHGenetics Initiative sample revealed
a total of ﬁve loci that were nominally signiﬁcant (P !
) under the narrow-phenotype model and ﬁve loci.05
under the broad-phenotype model (table 2). Only one
locus, on chromosome 18p11.2, had chromosomewide
signiﬁcance in either phenotype model after correction
for multiple tests. Under the narrow-phenotype model,
the maximum LOD score occurred near markerD18S37
(chromosome 18: 13,080,902–13,280,999 bp) in the
subset of families with the oldest mean AAO range: 22–
35 years. Here, the maximum LOD score increased from
0.13 to 2.92 ( ). This subset comprised 54 fami-Pp .001
lies, or 36% of the overall sample. Chromosome18p11.2
was also one of the top ﬁndings under the broad-phe-
notype model. Under this model, the LOD score in-
creased from 0.04 to 1.86 ( ) in a subset ofPp .039
families with a mean AAO age range of 24–35 years.
This subset comprised 46 families, or 31% of the sam-
ple. The OSA LOD scores along chromosome 18 are
shown in ﬁgure 6.
To further explore these ﬁndings, we examined the
clinical features in the subset of 54 families with the
oldest mean AAO who appeared to be most linked on
chromosome 18 under the narrow-phenotype model.
Compared with the rest of the sample, the subjects in
those families tended to have lower risks of alcohol abuse/
dependence (26.2% vs. 35.7%; ), rapid cy-Pp .004
cling (36.3% vs. 46.3%; ), and suicide attemptsPp .04
(14.9% vs. 25.2%; ), as well as a lower overallP ! .001
number of comorbidities (1.2 vs. 1.6; ). TheseP ! .001
ﬁndings were consistent with our report elsewhere that
AAO in BP is inversely associated with the risks of a
number of comorbid psychiatric disturbances (Lin et al.,
in press). Consideration of these other clinical features,
however, did not improve our ﬁndings on chromosome
18.
Discussion
We used two different approaches for incorporatingAAO
as a covariate in linkage analyses of BP and identiﬁed
two regions of interest. On chromosome 21q22.13, there
was evidence of linkage to earlier-onset BP, whereas, on
chromosome 18q11.2, there was evidence of linkage to
later-onset BP. Linkage has been reported to both loci
in previous studies. Interestingly, there was little evidence
of linkage in our sample until AAO information was
included in the analysis. These ﬁndings suggest thatAAO
may be a clinical marker of the underlying heterogeneity
in BP, demarcating subtypes of the disorder with distinct
genetic susceptibilities.
The strongest ﬁnding was on chromosome 21q22.13
in the relative-pair analysis of LODPAL. Empirical tests
with permutations suggested that the ﬁnding was signiﬁ-
cant at the chromosomewide level (threshold )P ! .0125
after correction for multiple tests. The ﬁnding did not
quite reach the genomewide level of signiﬁcance (thresh-
old ), but the corrections we employed wereP ! .0006
probably overly conservative, since the multiple tests
performed were not independent. Moreover, we have
found that the linkage signal on chromosome 21q22.13
was also strongest among individuals with early onset
in another independent sample, lending additional sup-
port to the ﬁnding in this 21q region. There were two
neighboring peaks identiﬁed under the narrow-pheno-
type model, but this ﬁnding resolved more clearly to
become one peak spanning ∼6 cM under the broad-
phenotype model. Genotyping a denser map of markers
across the region should help clarify the localization of
the ﬁnding.
The other ﬁnding of interest was on chromosome
18p11.2. In the relative-pair analysis of LODPAL, the
ﬁnding was only nominally signiﬁcant with permutation
tests, and we were unable to replicate the ﬁnding in an
independent sample. However, the locus emerged as one
of the top ﬁndings also in the family-level analysis of
OSA. The consistent ﬁndings with two different covari-
ate-based methods merit attention. Thus, further inves-
tigation of the region in this and other samples is needed
to conﬁrm the ﬁndings related to AAO.
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Figure 6 LOD scores along chromosome 18 from the LODPAL
and OSA analyses of the NIMH sample ( families) under thenp 150
broad- and narrow-phenotype models are presented. For the LODPAL
analyses, results from the one-covariate model with AAO as a con-
tinuous variable are shown. For the OSA analyses, results from the
high-to-low slicing of the data set are shown. Baseline models without
AAO, which generally yielded LOD scores !0.05, are not shown, for
the sake of clarity. The results from both sets of analyses converged
at chromosome 18p11.2 and showed increased evidence of linkage
among affected subjects with later-onset BP ( years).AAO 1 21
Several previous studies have reported linkage of BP
to 21q and 18p. As mentioned above, a linkage sig-
nal was detected on chromosome 21q, near markers
D21S1254, D21S65, D21S1440, andD21S1255, in the
97 families of the ﬁrst wave of the NIMH Genetics
Initiative (Detera-Wadleigh et al. 1997). However, this
linkage signal was not sustained in 53 families of the
second wave (Willour et al. 2003). When the two sam-
ples were combined, the linkage signal at this locus dis-
appeared altogether (McInnis et al. 2003a). To assess
whether the mixed evidence of linkage across samples
may be attributable to differences in AAO characteris-
tics, we compared the AAO distribution of the two sam-
ples and found that the proportion of affected individ-
uals from families with early-onset disease (proband’s
AAO 21 years) was signiﬁcantly greater in the ﬁrst
wave than in the second (73.4% vs. 63.0%; ).P ! .001
There have also been several reports of linkage to the
PFKL gene, which encodes phosphofructokinase, a key
regulatory enzyme in glycolysis. Straub and colleagues
(1994) found evidence for linkage to PFKL using a para-
metric dominant model ( ) and an affected-LODp 3.41
pedigree-member (APM) method ( ). OtherP ! .0003
studies have reported similar ﬁndings (Detera-Wadleigh
et al. 1996; Liu et al. 2001). In one follow-up study of
40 U.S. and Israeli pedigrees, Aita and colleagues (1999)
obtained a two-point heterogeneity ( ) LOD scoreap 0.5
of 3.35 ( ) atD21S1260,which is 5 cM fromP ! .000156
PFKL.
Linkage to chromosome 18p11.2 has been reported
in a number of previous studies as well. Berrettini and
colleagues (1994) ﬁrst reported linkage evidence at chro-
mosome region 18p11 in 22 white families. Using ASP
and APM methods, they obtained a P value of .0004
at marker D18S21 (∼3 Mb away from our peak ﬁnding
on chromosome 18 at D18S1150) under a broad-phe-
notype model similar to the one we tested. A number
of studies followed-up this ﬁnding and also detected
signiﬁcant linkage signals in the region (e.g., see Stine
et al. 1995; De Bruyn et al. 1996; Lin and Bale 1997;
Bennett et al. 2002). This region contains the IMPA2
gene, which encodes the enzyme myoinositol monophos-
phatase (IMPase) in the phospholipase C signaling path-
way, which can be inhibited by the mood-stabilizer lith-
ium at therapeutic levels (Sjoholt et al. 2000). It has
been suggested that IMPA2 promoter polymorphisms
are associated with BP (Sjoholt et al. 2004). In addition,
this region may harbor a gene contributing to the eti-
ology of both BP and schizophrenia (Berrettini 2000).
Despite these promising ﬁndings, not all studies
have observed linkage on chromosomes 21q22.13 and
18p11.2. The conﬂicting ﬁndings may be due to genetic
heterogeneity in BP. Some samples may be enriched for
affected subjects with susceptibility genes at either of
these two loci. AAO may reﬂect the underlying hetero-
geneity at these two loci and therefore may be used to
uncover previously obscured linkage in samples that are
less enriched. The strategy of using clinical features to
identify more-homogeneous subsets of affected subjects
to facilitate genetic mapping has been used successfully
in the past with other complex disorders (e.g., see Hall
et al. 1990; Pericak-Vance et al. 1991). The results of
the current study encourage wider application of this
strategy.
As described above, there are several different ap-
proaches to incorporating covariates into linkage analy-
ses. The approaches that we and others (Faraone et al.
2004) have used to examine AAO in BP have yielded
some divergent results. The divergent results may simply
be due to chance. On the other hand, they may provide
some insights into the nature of the underlying hetero-
geneity. For example, in our analyses, linkage to chro-
mosome 21q22.13 was identiﬁed by a relative-pair ap-
proach but not a family-level one. In the family-level
approach, the covariate of interest must be deﬁned at
the level of the family, such as by taking the mean,
minimum, or maximum value across all affected sub-
jects in the family. As a result, the family-level approach
may not be sensitive to linkage if there is intra- and
interfamilial heterogeneity at a locus. The fact that both
the relative-pair and family-level approaches identiﬁed
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Table 2
Nominally Signiﬁcant OSA Findings, by Chromosome, with AAO as the Key Covariate
Chromosome and
Phenotype Model
Nearest
Marker
Distance
from pter
(cM)
Baseline
LOD
Peak
LOD d LODa
Empirical
P
No. (%) of
Families
AAO Range
(years)
3:
Narrow D3S1763 209.9 .00 2.04 2.04 .044 31 (21) 5–9b
4:
Narrow D4S1625 165.5 .10 2.23 2.13 .036 29 (19) 20.3–35c
5:
Narrow D5S1354 250.9 .19 2.22 2.03 .045 39 (26) 18–31b
Broad D5S1354 209.9 .07 1.87 1.80 .040 32 (21) 18–31b
7:
Broad D7S1799 127.5 .37 1.75 1.38 .045 90 (60) 13–31b
9:
Broad D9S915 136.5 .48 3.03 2.55 .029 53 (36) 9.8–20c
15:
Narrow gata153f11 56.2 .20 2.83 2.63 .021 41 (27) 24–35c
Broad gata153f11 55.1 .06 2.31 2.25 .050 24 (16) 30.3–39.3c
18:
Narrow D18S37 45.2 .13 2.92 2.79 .001 54 (36) 22–35c
Broad D18S40 47.0 .04 1.86 1.82 .039 60 (40) 24.2–39.3c
NOTE.—Analysis was performed on the entire sample of 150 families.
a d LOD score denotes the difference between the peak LOD score and the baseline LOD score.
b Family-speciﬁc minimum values of AAO.
c Family-speciﬁc mean values of AAO.
linkage on chromosome 18p11.2 may suggest that there
is little intrafamilial heterogeneity at this locus. Inter-
estingly, none of the loci identiﬁed by Faraone and col-
leagues (2004) were detected in our analyses. Perhaps
this is not surprising, given that they examined a slightly
different sample and used a quantitative-trait approach
that may be better suited to searching for modiﬁer genes
that do not increase the susceptibility for a disorder per
se, but, rather, modify the AAO. Clearly, more meth-
odological work is needed to help interpret the divergent
results from the different covariate-based linkage analy-
ses and to clarify which are most appropriate to use
under various circumstances.
A notable limitation of the current study is that AAO
was deﬁned retrospectively on the basis of self-reported
information. The validity of such information may be
degraded by poor recall (i.e., recall bias). Subjects may
not be able to accurately report on their history of mood
symptoms. As a result, there may have been some error
in the assigned AAOs used in the current linkage analy-
ses. However, there is no reason to believe that the di-
rection of this error would be related in any way to the
genotype data. Random error of this sort would tend
to introduce noise into the linkage analyses and would
likely bias the ﬁndings toward the null. Despite this, we
still observed robust linkage signals on chromosomes
21q22.13 and 18p11.2. In addition, we reasoned that
subjects who might not be able to accurately recall the
exact age at disease onset would be able to distinguish
whether they had an early onset versus a late one. Thus,
we decided to examine AAO as both a continuous and
a dichotomous covariate. We used ﬁndings from a pre-
vious investigation of AAO in BP to empirically deter-
mine the most reasonable cutoff for the dichotomization
of AAO (Lin et al., in press).
The study also has several important strengths. First,
the study included one of the largest pedigree samples
of BP collected using common ascertainment and assess-
ment criteria. The large sample size provided improved
power for identiﬁcation of linkage with AAO as a co-
variate. Second, all subjects were assessed with the DIGS,
a widely used and well-validated instrument, and ex-
perienced clinicians used best-estimate procedures to as-
sign diagnoses of mood disorders. Thus, concerns about
misclassiﬁcation of affection status were minimized. Fi-
nally, the replication sample was ascertained and as-
sessed by the same team of researchers who played a
leading role in collecting the primary sample, which
ensured consistency across samples.
We have shown that AAO is potentially a clinical
marker of genetic heterogeneity in BP and that affected
subjects with early-onset versus late-onset disease may
carry variants of different susceptibility genes. Speciﬁ-
cally, we identiﬁed a locus on chromosome 21q22.13
that may harbor a susceptibility gene for earlier-onset
BP and another locus on chromosome 18p11.2 thatmay
harbor a susceptibility gene for later-onset BP. The ﬁnd-
ings encourage additional investigations in these regions.
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Future investigations should take into account infor-
mation on AAO to facilitate identiﬁcation of the rele-
vant susceptibility variants.
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